News
Coming soon
This is The Margin of Safety, a brand new site by George O'Toole that's just getting started. Things will be up and running here shortly, but you can subscribe in the meantime if you'd like to stay up to date and receive emails when
Company Analysis
SkinBioTherapeutics: Analysing Implied 750k Zenakine Royalties
SkinBioTherapeutics has not explicitly disclosed a £750k Zenakine royalty figure in its FY25 accounts, with commercial terms remaining confidential. However, the CEO has publicly acknowledged that straightforward arithmetic using figures in the annual report allows this amount to be inferred as attributable to Zenakine royalties. At first glance, a number
Company Analysis
Grainger: Earnings Grow, Valuations Wait
Grainger is a straightforward company by listed property standards. Its value is best understood through the scale of its operations, the shift to REIT status, and the macro backdrop for UK rental housing. The latest full-year results cover the year to September 2025, which margin has reviewed alongside subsequent disclosures.